Low RYR2 Level Relates to Poor Prognosis of Patients With Lung Adenocarcinoma by Promoting Tumor Cell Proliferation and Inhibiting Immune Cell Infiltration

Documenti analoghi

• PRKAA2 Promotes Tumor Growth and Inhibits Ferroptosis through SLC7A11/GSH/GPX4 Pathway in Non‐Small Cell Lung Cancer
  di: Zhiqiang Wei, et al.
  Pubblicazione: (2024)
• High Expression of PDIA4 Contributes to Poor Prognosis in Glioma
  di: Yang Liu, et al.
  Pubblicazione: (2025)
• Rosmanol Suppresses Nasopharyngeal Carcinoma Cell Proliferation and Enhances Apoptosis, the Regulation of MAPK/NF‐κB Signaling Pathway
  di: Weiping Tao, et al.
  Pubblicazione: (2025)
• Apelin‐13 Inhibits the Adhesion of Monocytes to Endothelial Cells via the Gfi1/NF‐κB Signaling Pathway
  di: Yujuan Wei, et al.
  Pubblicazione: (2025)
• Construction of an Osteoarthritis Diagnostic Model Based on Hub Immune Cells and Genes by Machine Learning Method
  di: Rong Jiang, et al.
  Pubblicazione: (2025)